Details for Patent: 8,030,313
✉ Email this page to a colleague
Which drugs does patent 8,030,313 protect, and when does it expire?
Patent 8,030,313 protects ABILIFY MAINTENA KIT and is included in one NDA.
This patent has forty-four patent family members in thirty-two countries.
Summary for Patent: 8,030,313
| Title: | Controlled release sterile injectable aripiprazole formulation and method |
| Abstract: | A controlled release sterile freeze-dried aripiprazole formulation is provided which is formed of aripiprazole of a desired mean particle size and a vehicle therefor, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks. A method for preparing the controlled release freeze-dried aripiprazole formulation, and a method for treating schizophrenia employing the above formulation are also provided. |
| Inventor(s): | Kostanski; Janusz W. (Princeton, NJ), Matsuda; Takakuni (Tokushima, JP), Nerurkar; Manoj (Monmouth Junction, NJ), Naringrekar; Vijay H. (Princeton, NJ) |
| Assignee: | Otsuka Pharmaceutical Co., Ltd. (Tokyo, JP) |
| Application Number: | 11/979,149 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,030,313 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 8,030,313
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-001 | Feb 28, 2013 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF SCHIZOPHRENIA | ⤷ Sign Up | ||||
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-001 | Feb 28, 2013 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF SCHIZOPHRENIA, WITH EFFICACY IN TREATING ACUTE EPISODES OF SCHIZOPHRENIA | ⤷ Sign Up | ||||
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-003 | Sep 29, 2014 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF SCHIZOPHRENIA, WITH EFFICACY IN TREATING ACUTE EPISODES OF SCHIZOPHRENIA | ⤷ Sign Up | ||||
| Otsuka Pharm Co Ltd | ABILIFY MAINTENA KIT | aripiprazole | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR | 202971-003 | Sep 29, 2014 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF SCHIZOPHRENIA | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,030,313
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1675573 | ⤷ Sign Up | CA 2014 00026 | Denmark | ⤷ Sign Up |
| European Patent Office | 1675573 | ⤷ Sign Up | C300669 | Netherlands | ⤷ Sign Up |
| European Patent Office | 1675573 | ⤷ Sign Up | 92427 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 1675573 | ⤷ Sign Up | PA2014020 | Lithuania | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
